Keyphrases
Virus
81%
Capsid
73%
Rous Sarcoma Virus
62%
Pregenomic RNA (pgRNA)
58%
Gag Protein
50%
Integrase
49%
COVID-19
49%
Human Immunodeficiency Virus Type 1 (HIV-1)
46%
Cryogenic Electron Microscopy
34%
Retrovirus
32%
Plasmodium Falciparum
32%
Retroviral Integrase
29%
Canine Parvovirus
27%
Proviral DNA
27%
Malaria
25%
Infectious Diseases
25%
Virion
25%
Confidence Interval
22%
Remdesivir
21%
Methicillin-resistant Staphylococcus Aureus
21%
Parvovirus
20%
Retroviral Gag Protein
19%
Enterovirus 71 (EV71)
18%
Western Kenya
18%
Cerebral Malaria
17%
Complement Receptors
17%
Pennsylvania
17%
Falciparum Malaria
17%
Plasma Membrane
16%
Anemia
16%
Host Factors
16%
Viral
16%
Coxsackievirus B3 (CVB3)
16%
Severe Malaria
15%
AIDS/HIV
15%
Erythrocytes
15%
Gag Polyprotein
15%
Epitope
15%
Transferrin Receptor 1 (TfR1)
14%
Nuclear Trafficking
14%
Antibiotics
14%
Host Range
13%
Red Cells
13%
COVID-19 Pandemic
13%
RNA Dimerization
13%
Amino Acids
13%
West Nile Virus
12%
HPV16
12%
Virus Assembly
12%
Matrix Domain
12%
Malaria Vaccine
12%
Immune Complex
11%
Monoclonal Antibody
11%
Icosahedral
11%
Nuclear Export
11%
Treatment Trials
11%
Host Cell
11%
Decay Accelerating Factor
11%
Clostridium Difficile Infection
11%
Meta-analysis
10%
Systematic Meta-analysis
10%
Complement Regulatory Proteins
10%
Endonuclease Activity
10%
High-risk Human Papillomavirus (HR-HPV)
10%
Clinical Outcomes
10%
Procapsid
10%
United States
10%
Transplantation
9%
Dimerization
9%
Immunization
9%
Receptor-ligand Interaction
9%
Complement Activation
9%
Virus-like Particles
9%
Sporozoite
9%
Epidemiology
9%
Binding Site
9%
Fever
9%
Non-viral
9%
Hospitalization
9%
Antimicrobial
9%
Nuclear Entry
9%
Genomic RNA Packaging
8%
Red Blood Cells
8%
Medical Center
8%
Sialic Acid
8%
Neutralizing Antibodies
8%
Capsomer
8%
Target Site Selection
8%
RNA-protein Complex
8%
Odds Ratio
8%
Immunocompromised Patients
8%
Receptor Binding
8%
Influenza
8%
Viral Genome
8%
Nuclear Export Signal
8%
Hospitalized Adults
8%
CD55
8%
Icosahedral Viruses
8%
Circumsporozoite Protein
8%
Endocarditis
8%
Immunology and Microbiology
Capsid
100%
Human Immunodeficiency Virus 1
68%
Rous Sarcoma Virus
60%
Integrase
53%
Virus
45%
Plasmodium falciparum
44%
Cryo-Electron Microscopy
38%
Virion
37%
Retrovirus
32%
Erythrocyte
24%
Parvoviridae
23%
Canine Parvovirus
22%
Virus Nucleocapsid
21%
Enterovirus A71
18%
Binding Site
18%
Virus Particle
18%
Complement Receptor 1
18%
Decay-Accelerating Factor
17%
Epitope
17%
Cell Membrane
17%
Wild Type
16%
Host Factor
16%
Methicillin-Resistant Staphylococcus Aureus
16%
Human Immunodeficiency Virus
15%
Visna Virus
15%
Severe Acute Respiratory Syndrome Coronavirus 2
14%
Coxsackievirus B3
14%
Complement Activation
14%
Nuclear Export
14%
Viral Replication
14%
COVID-19
13%
Virus Assembly
13%
Receptor Binding
12%
Amino Terminal Sequence
12%
Human Papillomavirus Type 16
12%
Host Cell
12%
Monoclonal Antibody
11%
Amino Acid
11%
Neutralizing Antibody
11%
Immune Complex
11%
Dimerization
11%
Infectious Agent
11%
Bacteriophage
11%
RTS,S
10%
Carboxy Terminal Sequence
10%
Host Range
10%
Spike
10%
Influenza
10%
Picornaviridae
10%
Viral Protein
10%
Respiratory Syncytial Virus
9%
Conformational Transition
9%
Staphylococcus Aureus
9%
Surface Property
9%
Vaccine Efficacy
9%
Viral Disease
8%
Nuclear Localization Signal
8%
Hemocyte
8%
DNA Binding Protein
8%
Infectious Disease
8%
Aves
8%
Minute Virus of Mice
8%
Blood Plasma
8%
Enterovirus
7%
Nuclear Export Signal
7%
Viral Load
7%
Virus Attachment
7%
Wart Virus
7%
Sporozoite
7%
Virus-Like Particle
7%
Circumsporozoite Protein
7%
Membrane Binding
7%
Crystal Structure
7%
Neutralization
6%
Merozoite
6%
Prevalence
6%
Plasmodium
6%
Adenoviridae
6%
Parvovirus
6%
Mouse Mammary Tumor Virus
5%
Binding Antibody
5%
Alcoholysis
5%
Morphogenesis
5%
Murine
5%
Cell Interaction
5%
Influenza Vaccine
5%
Plasmodium vivax
5%
Peptoclostridium difficile
5%
Complement System
5%
P-Selectin Glycoprotein Ligand-1
5%
Immunogenicity
5%
Nuclease
5%
Mimivirus
5%
Nuclear Import
5%
Immunoglobulin F(ab) Fragment
5%
Life Cycle
5%
Virus Morphology
5%
Face
5%
Enterovirus B
5%